Jobs at Ocular Therapeutix, Inc. (Now Hiring) — 13 open

Senior Director, Clinical Development

Remote OK

$247k–$275k/yr

Senior$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Clinical development, Clinical trials, Ophthalmology, Regulatory affairs, NDA

QTSS Administrator, I or II

Bedford, England, United Kingdom · On-site

$62k–$68k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: LabWare LIMS, Empower 3, Computer System Validation, 21 CFR Part 11, Data Management

Executive Director, Trade and Distribution

United States · On-site

$300k–$320k/yr

Senior+$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Trade Strategy, Channel Management, Specialty Distribution, Buy-and-Bill Reimbursement, Market Access

Associate Medical Director

Portland, Oregon, United States · On-site

$190k–$230k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Medical Affairs, Clinical Trial Enrollment, KOL Engagement, Scientific Communication, Data Analysis

Analytical Chemist II

Bedford, England, United Kingdom · On-site

$98k–$105k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: HPLC, UPLC, GPC, SEC, Empower

Senior Associate, Records Management

Bedford, England, United Kingdom · Hybrid

$98k–$110k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Records Management, Technical Writing, Software Documentation, MasterControl, eDMS

Research Associate II, Quality Control

Bedford, England, United Kingdom · On-site

$98k–$110k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: HPLC, UPLC, GC, KF, Dissolution

Process Engineer, MSAT

Bedford, England, United Kingdom · On-site

$94k–$125k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Process Development, Experimental Design, cGMP Manufacturing, Technical Transfer, Scale-up

Manager, Quality Management Systems & Validations

Bedford, England, United Kingdom · On-site

$143k–$152k/yr

Senior+$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Quality Management Systems, QA Validations, GxP Compliance, CAPA Management, Change Control

Data Review Specialist, Quality Control

Bedford, England, United Kingdom · On-site

$98k–$113k/yr

Senior$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Analytical data review, Quality control, cGMP, GLP, ALCOA+

Assistant Corporate Controller

Bedford, England, United Kingdom · On-site

$200k–$227k/yr

Senior+$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: U.S. GAAP, SEC Reporting, SOX Compliance, Financial Reporting, Technical Accounting

Manager, Business Operations/Events

Remote OK

$120k–$135k/yr

Senior$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Pharmaceutical meeting planning, Project management, Business operations, Compliance, Vendor management

Key Account Manager - Columbus, Ohio

Columbus, Ohio, United States · On-site

$165k–$172k/yr

Mid level$1.2B raised

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bi…

Skills: Account Management, Pharmaceutical Sales, Ophthalmology, Medical Reimbursement, Clinical Training

About Ocular Therapeutix, Inc.

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Founded
2006
Headquarters
Bedford, MA
LinkedIn followers
36,786
Total funding
$1.2B

Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLI™ (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYX™ technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME).

Offices: 15 Crosby Drive, Bedford, MA 01730, US

RetinaRetinal DiseaseWet AMDNPDRDMEAnti-VEGFTyrosine Kinase InhibitorsOcular Drug DeliverySustained DeliveryOphthalmic Therapies
View all jobs at Ocular Therapeutix, Inc.